For example, one competitor noted that the acquisition "will allow Mars to have
access to significant sensitive and confidential information regarding [COMPETITOR] as well as other pet food suppliers."150 Another competitor raised similar concerns, noting that: "As [Mars] are worldwide and European coleaders in the "therapeutic" pet food business, we believe that it might impact negatively the relationship of the other players with those clinics (risk of leak of confidential information, lack of trust, partial choice of brand or even dereferencing of brand….)."